Pamrevlumab Biosimilar – Anti-CTGF, IGFBP-8 mAb – Research Grade

Reference:
Size

,

Isotype

IgG1, kappa

Brand

Product type

Clonality

Expression system

Applications

,

Product namePamrevlumab Biosimilar - Anti-CTGF, IGFBP-8 mAb - Research Grade
SourceCAS 946415-13-0
SpeciesHomo sapiens
Expression systemMammalian cells
Purity>85%
BufferPBS buffer PH7.5
Delivery conditionBlue ice (+4°C)
Delivery Time3-5 days if in stock; 3-5 weeks if production needed
Storage conditionstore at -80°C
BrandProteoGenix
Aliases /SynonymsPamrevlumab,FG-3019,CTGF, IGFBP-8,anti-CTGF, IGFBP-8
ReferencePX-TA1386
NoteFor research use only. Not suitable for clinical or therapeutic use.
IsotypeIgG1-kappa
ClonalityMonoclonal Antibody

Description of Pamrevlumab Biosimilar - Anti-CTGF, IGFBP-8 mAb - Research Grade

General information on Anti-CTGF/IGFBP-8[Homo sapiens] (Pamrevlumab) Monoclonal Antibody

Pamrevlumab is investigated in the treatment of Type 2 Diabetes Mellitus and Kidney Disease.

SDS-PAGE for Pamrevlumab Biosimilar - Anti-CTGF, IGFBP-8 mAb

Pamrevlumab Biosimilar - Anti-CTGF, IGFBP-8 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.

Reviews

There are no reviews yet.

REVIEW YOUR PRODUCT

Be the first to review “Pamrevlumab Biosimilar – Anti-CTGF, IGFBP-8 mAb – Research Grade”

Your email address will not be published. Required fields are marked *

Related products

CTGF / CCN2, C-Fc, recombinant protein
Antigen

CTGF / CCN2, C-Fc, recombinant protein

PX-P5669 420€

Contact us

Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.






    Cart (0 Items)

    Your cart is currently empty.

    View Products